Chong Kun Dang Pharmaceutical Corp.
Develops and manufactures drugs for systemic anti-infectives and metabolic diseases.
185750 | KO
Overview
Corporate Details
- ISIN(s):
- KR7185750007
- LEI:
- Country:
- South Korea
- Address:
- 서울 서대문구 충정로3가 3가 368 종근당빌딩, 서대문구
- Website:
- https://www.ckdpharm.com
- Sector:
- Manufacturing
Description
Chong Kun Dang Pharmaceutical Corp. is a pharmaceutical company focused on the research, development, manufacturing, and commercialization of a broad range of medicines. Its portfolio encompasses prescription drugs, over-the-counter (OTC) products, and health supplements. The company is committed to innovation, with significant investment in R&D to develop novel treatments. Key therapeutic areas of focus include systemic anti-infectives and metabolic diseases. Through a robust pipeline and extensive clinical trials, the company develops quality medicines to improve public health and quality of life.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2025-08-29 00:00 |
투자판단관련주요경영사항 (텔미누보정(CKD828) 식품의약품안전처 국내 품목허가 승인)
|
Korean | 7.2 KB | ||
| 2025-08-22 00:00 |
투자판단관련주요경영사항 (텔미누보정(CKD828) 식품의약품안전처 국내 품목허가 신청)
|
Korean | 13.5 KB | ||
| 2025-08-14 00:00 |
반기보고서 (2025.06)
|
Korean | 4.9 MB | ||
| 2025-08-01 00:00 |
영업(잠정)실적(공정공시)
|
Korean | 13.3 KB | ||
| 2025-07-24 00:00 |
공정거래자율준수프로그램운영현황(안내공시)
|
Korean | 15.8 KB | ||
| 2025-06-24 00:00 |
주식등의대량보유상황보고서(일반)
|
Korean | 99.9 KB | ||
| 2025-06-12 00:00 |
유형자산취득결정
|
Korean | 7.9 KB | ||
| 2025-06-12 00:00 |
풍문또는보도에대한해명(미확정)
|
Korean | 8.0 KB | ||
| 2025-06-10 00:00 |
풍문또는보도에대한해명(미확정)
|
Korean | 6.2 KB | ||
| 2025-06-02 00:00 |
기업지배구조보고서공시
|
Korean | 1.8 MB | ||
| 2025-05-22 00:00 |
기타경영사항(자율공시) (CKD510 기술수출 관련 마일스톤 수령)
|
Korean | 5.2 KB | ||
| 2025-05-15 00:00 |
분기보고서 (2025.03)
|
Korean | 2.9 MB | ||
| 2025-04-30 00:00 |
영업(잠정)실적(공정공시)
|
Korean | 13.3 KB | ||
| 2025-04-23 00:00 |
투자판단관련주요경영사항 (듀비엠폴서방정(CKD383) 식품의약품안전처 국내 품목허가 신청)
|
Korean | 16.9 KB | ||
| 2025-04-23 00:00 |
투자판단관련주요경영사항 (듀비엠파정(CKD398) 식품의약품안전처 국내 품목허가 신청)
|
Korean | 16.6 KB |
Automate Your Workflow. Get a real-time feed of all Chong Kun Dang Pharmaceutical Corp. filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for Chong Kun Dang Pharmaceutical Corp.
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Chong Kun Dang Pharmaceutical Corp. via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
